(Q48136292)

9 February 2018

title

No association of MDM2 SNP309 with risk of glioblastoma and prognosis. (English)

1 reference

9 February 2018

1 reference

4

1 reference

9 February 2018

Ahmed Idbaih

object named as

Ahmed Idbaih

3

0 references

author name string

Soufiane El Hallani

1

1 reference

9 February 2018

Yannick Marie

2

1 reference

9 February 2018

Blandine Boisselier

5

1 reference

9 February 2018

Florence Laigle-Donadey

6

1 reference

9 February 2018

François Ducray

7

1 reference

9 February 2018

Jean-Yves Delattre

8

1 reference

9 February 2018

Marc Sanson

9

1 reference

9 February 2018

publication date

14 June 2007

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

85

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

241-244

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-007-9416-1

exact match

0 references

cites work

Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population

1 reference

12 December 2020

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

1 reference

12 December 2020

Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk.

1 reference

12 December 2020

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

1 reference

12 December 2020

Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population

1 reference

12 December 2020

MDM2 SNP309 and SNP354 are not associated with lung cancer risk.

1 reference

12 December 2020

Primary brain tumours in adults.

1 reference

12 December 2020

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer

1 reference

12 December 2020

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

1 reference

12 December 2020

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

1 reference

12 December 2020

Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas

1 reference

12 December 2020

MDM2 T309G polymorphism is associated with bladder cancer

1 reference

12 December 2020

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

12 December 2020

Molecular changes in gliomas

1 reference

12 December 2020

Prognostic impact of molecular markers in a series of 220 primary glioblastomas.

1 reference

12 December 2020

MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis

1 reference

12 December 2020

MDM2 SNP309 accelerates colorectal tumour formation in women.

1 reference

12 December 2020

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

1 reference

12 December 2020

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

1 reference

12 December 2020

No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites

1 reference

12 December 2020

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

1 reference

12 December 2020

MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C

1 reference

12 December 2020

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

1 reference

12 December 2020

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

1 reference

12 December 2020

10.1007/S11060-007-9416-1

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17568997

1 reference

9 February 2018